J&J says its lung cancer drug combination keeps people alive longer
Niels Wenstedt | Getty ImagesJohnson & Johnson on Tuesday said its lung cancer regimen keeps people alive for at least a year longer than AstraZeneca's Tagrisso, the go-to drug for a certain type of lung cancer.J&J in a statement…